[Neuroendocrine syndromes with toxoplasmic origin: clinical and therapeutic considerations].
D000328:Adult; D001927:Brain Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D002648:Child; D002738:Chloroquine / Q000627:therapeutic use; D005260:Female; D005277:Fenfluramine / Q000627:therapeutic use; D006801:Humans; D011739:Pyrimethamine / Q000627:therapeutic use; D013421:Sulfamethoxypyridazine / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
D005277:Fenfluramine; D002738:Chloroquine; D013421:Sulfamethoxypyridazine; D011739:Pyrimethamine
Sindromi neuroendocrine ad eziologia toxoplasmica: considerazioni cliniche e terapeutiche.